Injective (INJ) Retests Trading Range as LI.FI Integration Expands Cross-Chain Connectivity
Key Takeaways
- •INJ is currently trading at $4.53 with a market capitalization of $453.8 million and a 24-hour gain of 1.29%.
- •The token has returned to its prior consolidation zone after giving back part of a 20% rally, with a decisive breakout above resistance potentially targeting $6.
- •A newly announced LI.FI integration connects Injective to more than 60 blockchain networks and over 1,000 applications through a single cross-chain transfer interface.
- •The integration reduces friction in cross-chain liquidity transfers for INJ and native USDC tokens, addressing historical connectivity limitations between Cosmos-ecosystem chains and Ethereum-compatible networks.
- •Broader crypto market conditions remain cautious, and traders are monitoring whether INJ can maintain support within its established range and resume bullish momentum.
Injective (INJ) is retesting its previous trading range as traders monitor the token for renewed bullish momentum. A newly announced LI.FI integration is expanding the protocol's cross-chain connectivity, broadening access to liquidity and decentralized applications across the broader blockchain ecosystem.
At the time of writing, INJ is trading at $4.53, with a 24-hour trading volume of $70.28 million and a market capitalization of $453.8 million, according to CoinMarketCap. The token has gained 1.29% over the past 24 hours.
Price Retests Consolidation Zone With $6 Target in View
Injective (INJ) has surrendered part of a recent 20% rally after breaking out from a well-defined trading range. The subsequent pullback has returned INJ to its prior consolidation zone, reflecting continued uncertainty in the broader market. With neither buyers nor sellers firmly in control, traders remain cautious while watching whether the range continues to provide support.
Despite the retracement, INJ's technical structure remains notable as long as the price stays within the established range. A breakout above resistance could reestablish a bullish trend, with a potential price target of $6.
LI.FI Integration Connects Injective to 60+ Blockchains
Injective has expanded its cross-chain reach through a new LI.FI integration, connecting the ecosystem to a network spanning more than 60 blockchain networks and over 1,000 applications. LI.FI aggregates bridge and decentralized exchange routes across major chains, enabling users to find efficient cross-chain transfer paths through a single interface. The integration reduces friction in cross-chain liquidity transfers and bridge operations, broadening the network's distribution capabilities.
The integration also creates additional pathways for moving INJ and native USDC tokens through Injective. Users can complete cross-chain transactions more seamlessly without navigating multiple bridges and liquidity sources separately. For Injective, a Layer-1 blockchain built specifically for finance applications using the Cosmos SDK, deeper interoperability addresses a longstanding challenge for Cosmos-ecosystem chains, which have historically operated with comparatively limited direct connectivity to Ethereum-compatible networks. As demand for interoperability continues to grow across the Layer-1 landscape, the development could strengthen Injective's position in the wider on-chain ecosystem.
Market Outlook
Following the network expansion and optimistic price projections, INJ has been trading in positive territory. However, the broader crypto market trend remains cautious, and any breakout could risk becoming a fakeout if bearish conditions persist.
Injective traders are closely monitoring whether INJ can hold its prior trading range and resume bullish momentum. A decisive break above resistance would reinforce the recovery narrative and bring the $6 level into focus. Meanwhile, LI.FI's expanding cross-chain interoperability may further enhance liquidity access for the ecosystem, though the extent to which the integration translates into sustained on-chain activity remains to be seen.
